The overall rating is Sell. ALGO is at $0.084881, down 3.34% over 24 hours, and sits only $0.000485 above its $0.084396 low, about 10% of the way up from the low across the stated daily range. Its proximity to the session low, together with the negative daily change, indicates that the latest price action is weak rather than showing a clear recovery.

The supplied hourly moving averages are all above the current price: the 8-hour SMA is $0.0857 and the 144-hour SMA is $0.0904, with the intermediate averages also between those values. The reported gaps range from 0.90% below the 8 SMA to 6.11% below the 144 SMA, so weakness is evident across both shorter and longer averaging windows; price has not reclaimed even the shortest listed average.

Momentum data reinforce the bearish reading across multiple periods. ALGO is down 10.53% over seven days, 10.45% over 14 days, and 25.89% over 30 days, showing that the decline extends beyond the latest 24-hour move. The similar seven- and 14-day losses indicate little improvement in those measured periods, while the larger 30-day loss points to a more pronounced decline over the month.

The 1-hour RSI of 27 is the main counter-signal: it is low enough to indicate oversold short-term conditions and raises the possibility of a rebound. However, the 7-day RSI is 42, and the supplied price data show no corresponding reversal; therefore, the hourly RSI alone is not strong evidence that the broader decline has ended. It may describe short-term selling pressure as stretched, but it does not outweigh the negative trend and momentum readings.

Reported 24-hour volume is 36,482,420, and volume-to-market-cap is 4.73%. Without historical volume figures or a comparison benchmark, these numbers do not establish whether participation is unusually strong or weak, so they provide limited directional confirmation. The all-time high of $3.56, recorded in 2019, is far above the current price, but that historical distance does not identify a near-term turning point or price level.

Overall, the balance of the supplied evidence favors Sell rather than Hold or Buy: price is near its daily low, remains below every listed moving average, and has declined across the seven-, 14-, and 30-day periods. The primary counterargument is the 1-hour RSI of 27, which suggests short-term oversold conditions, but the 7-day RSI of 42 and the absence of a demonstrated price recovery leave that signal insufficient to reverse the bearish assessment.